Navigation Bordeaux Population Health Research Center (BPH) - UMR 1219 par Auteur "WALLET, Cedrick"
-
Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan
AUZANNEAU, C.; BACQ, D.; BELLERA, Carine ...(European Society for Medical Oncology. vol. 5, n° 4, 2020)Article de revue -
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial
BERNARDINO, J. I.; MOCROFT, A.; WALLET, Cedrick ...(PLoS ONE. vol. 14, n° 1, pp. e0209911, 2019)Article de revueLibre accès -
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
ITALIANO, Antoine; DINART, Derek; SOUBEYRAN, Isabelle ...(BMC Cancer. vol. 21, n° 1, pp. 1180, 2021-11-05)Article de revueLibre accès -
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals
CHALOUNI, Mathieu; RODRIGUEZ-CENTENO, J.; SAMRI, A. ...(PLoS ONE. vol. 15, n° 4, pp. e0230772, 2020)Article de revueLibre accès -
Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial
AMMASSARI, A.; STOHR, W.; ANTINORI, A. ...(Journal of acquired immune deficiency syndromes (1999). vol. 79, n° 4, pp. 481-490, 2018-08-27)Article de revue -
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial
ESTEBAN-CANTOS, Andres; RODRIGUEZ-CENTENO, Javier; BARRUZ, Pilar ...(Lancet HIV. vol. 8, n° 4, pp. e197-e205, 2021-04)Article de revue -
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1
STELLA-ASCARIZ, N.; MONTEJANO, R.; RODRIGUEZ-CENTENO, J. ...(Journal of Infectious Diseases. vol. 218, n° 10, pp. 1523-1530, 2018-10-05)Article de revue -
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns
ESTEBAN-CANTOS, Andres; RODRIGUEZ-CENTENO, Javier; SILLA, Juan C. ...(EBioMedicine. vol. 88, 2023-02)Article de revueLibre accès -
Determinants of blood telomere length in antiretroviral treatment-naive HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial
ALEJOS, B.; STELLA-ASCARIZ, N.; MONTEJANO, R. ...(HIV Medicine. vol. 20, n° 10, pp. 691-698, 2019)Article de revue -
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
DUVIGNAUD, Alexandre; LHOMME, Edouard; ONAISI, Racha ...(Clinical Microbiology and Infection. vol. 28, n° 7, pp. 1010-1016, 2022-07-01)Article de revueLibre accès -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
POLLARD, A. J.; LAUNAY, O.; LELIEVRE, J. D. ...(The Lancet Infectious Diseases, 2020-11-17)Article de revue